Flumazenil
(a)
is a competitive benzodiazepine antagonist
(b)
is an inverse agonist at the benzodiazepine receptor
(c)
has a relatively short half-life
(d)
is useful in treating hepatic encephalopathy
(e)
is indicated in status epilepticus
(a) true (b)
false (c)
true (d)
false (e)
false
No comments:
Post a Comment